HOME >> BIOLOGY >> NEWS
Findings give insight into how colon cells transform into precancerous polyps

A key signaling pathway appears to be critical to the earliest transformation of normal colon cells into growths called polyps that may advance to colon tumors, Vanderbilt-Ingram Cancer Center scientists have reported.

The findings suggest that, someday, doctors might use drugs that interrupt this pathway to treat individuals who are found to have colon cells on the verge of this transformation. The goal would be to prevent polyps -- and thus colon cancer -- from ever developing.

"Clearly, were a long way from doing that, but the prospects are very exciting," said Dr. Robert J. Coffey, Ingram Professor of Cancer Research and professor of Medicine and Cell Biology. Coffeys laboratory, in collaboration with the laboratory of David Threadgill, Ph.D., reported their findings recently in the Proceedings of the National Academy of Sciences.

The signalling pathway involves the epidermal growth factor receptor and the "ligands" that bind to it. The receptor sits across the cell surface, much like a satellite dish. The ligand fits into the receptor to transmit signals into the cell that prompt its growth. Scientists are focused on this pathway as more is learned about how it is involved in cancer development and progression and as new drugs are developed to interrupt it.

The Vanderbilt work helps clarify contradictory findings reported more than a year ago by two different groups. One group observed a 90 percent reduction in polyp formation when they used an inhibitor of EGFr in Min mice, a strain that is genetically engineered to develop hundreds of colon polyps. The other group did a similar experiment with a similar drug and found no effect.

So the Vanderbilt researchers instead turned to genetics. They took advantage of a mouse called waved2 that has a naturally occurring mutation in the EGFr tyrosine kinase domain (the section beneath the cell surface) that results in a 90 percent reduction in EGFr activity. These
'"/>

Contact: Cynthia Manley
cynthia.manley@mcmail.vanderbilt.edu
615-354-0936
Vanderbilt University Medical Center
19-Apr-2002


Page: 1 2

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Findings redefine mechanism of action of RNA helicase enzymes
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Findings could aid efforts to harness nature for making drugs
5. Findings offer clue to how molecule can both stimulate, suppress cell growth
6. Findings offer further understanding about growth and development in young male gymnasts
7. Findings in frog oocytes may help study of chromosome physiology
8. Findings aid understanding of neurodegenerative diseases
9. Findings show exceptional longevity runs in families
10. Findings conclude sustained caffeine intake negates the benefits of creatine supplements
11. Findings link disease specific anitbodies to activation of T cells for the first time

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... 16, 2019 , ... LeadingBiotech , an exclusive event ... its NY/NJ CEO conference to be held on November 5, 2019 ... The event offers senior-level industry leaders a unique opportunity to collaborate, build partnerships ...
(Date:10/11/2019)... ... , ... Advanced Clinical, a clinical research services organization, is ... appointed Therapeutic Lead for Oncology. Dr. Tyan brings a wealth of practical, therapeutic, ... delivery credentials previously offered at Advanced Clinical. , Dr. Tyan has worked extensively ...
(Date:10/10/2019)... ... October 10, 2019 , ... Mindray, a ... attendees of the American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit ... 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare professionals from ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Today marked the ... is enabling clinical program outsourcing success by cultivating radical improvements in leadership, staff, ... veteran executive Brenda Reese, phaseUP™ brings clients deep, broad and unique expertise in ...
(Date:10/3/2019)... (PRWEB) , ... October 02, 2019 , ... eKare’s inSight® ... NHS Digital Health Accelerator run by the East Midlands Academic Health Science Network (EMAHSN), ... adoption of technology in NHS by providing support to develop and deploy solutions to ...
(Date:10/3/2019)... ... 2019 , ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials ... Sherley, M.D., Ph.D., discussed important design factors that currently limit the success of early ... suppliers of clinical trials, in his talk Dr. Sherley focused on the ...
(Date:9/24/2019)... WEST LAFAYETTE, Ind. (PRWEB) , ... ... ... Pharma LLC will be presenting their latest research in the area of ... Monday, November 4th, Dr. Pamela Smith, COO of Improved Pharma, will present ...
Breaking Biology Technology:
Cached News: